Cell-intrinsic engineering strategies using a truncated Fas receptor can successfully disrupt death-receptor signaling and improve the efficacy of T cell therapy in a mouse melanoma model,19 but such dominant-negative Fas molecules still lack co-stimulatory signals that may be critical for T cell persistence in some TMEs. This evidence concerns the gene FAS and melanoma.